Continuous use makes sense for users still experiencing ongoing improvements without plateau suggesting continued benefit from sustained application, highly satisfied with current results wanting to maintain peak benefits without decline risk, financially comfortable with indefinite product investment as skincare priority, psychologically comfortable with long-term commitment to effective treatment, experiencing rapid benefit decline during previous break attempts indicating necessity of ongoing application, and prioritizing maximum results over cost optimization or flexibility concerns
A phase 2 randomised placebo controlled double-blind trial (IIH:Pressure trial) demonstrated the efficacy of exenatide at significantly reducing ICP, as measured using highly accurate telemetric ICP monitors, in people with IIH [19]
Experimental methods that assess memory functions often measure the speed or accuracy of response to a certain task (101)
For companies across the pharmaceutical value chain, the opportunity is not just to follow the shift from injectables to oral delivery
Immunity (2001) 14:16979
Yes, always taper, she says